Topical nonsteroidal anti-inflammatory drugs in uncomplicated cataract surgery: Effect of sodium naproxen

European Journal of Ophthalmology

Volumn 15, Issue 5, 2005, Pages 598-606

  Russo, Pietro ^a   Papa, V ^a   Russo, S ^a   Di Bella, A ^a   Pabst, G ^b   Milazzo, G ^a   Balestrazzi, A ^c   Caporossi, A ^c  

^a SIFI SpA   (Italy)

^b AAI Deutschland GmbH and Co KG   (Germany)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Cataract surgery; Naproxen; NSAID; Ocular inflammation

Indexed keywords

CIPROFLOXACIN; CORTICOSTEROID; DICLOFENAC; LOMEFLOXACIN; NAPROXEN; NETILMICIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; OFLOXACIN;

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EVALUATION; EYE INFLAMMATION; FEMALE; HUMAN; IRITIS; KERATITIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLIT LAMP; TREATMENT OUTCOME;

EID: 26444452666     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500510     Document Type: Article

References (33)

1. El-Harazi SM, Feldman RM. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthalmol 2001; 12: 4-8.
2. Flach AJ. Discussion by Allan J Flach, MD. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin 2002; 42: 1-11.
3. Simone JN, Whitacre MM. Effects of anti-inflammatory drugs following cataract extraction. Curr Opin Ophthalmol 2001; 12: 63-7.
4. Dinning WJ. Steroids and the eye-indications and complications. Postgrad Med J 1976; 52: 634-8.
5. Waterbury L, Kunysz EA, Beuerman R. Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing. J Ocul Pharmacol 1987; 3: 43-54.
6. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992; 36: 259-84.
7. Koay P. The emerging roles of topical non-steroidal antiinflammatory agents in ophthalmology. Br J Ophthalmol 1996; 80: 480-5.
8. Todd PA, Clissold SP. Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs 1990; 40: 91-137.
9. Roszkowski AP, Rooks WH 2nd, Tomolonis AJ, Miller LM. Anti-inflammatory and analgetic properties of d-2-(6'-methoxy-2'-naphthyl)-propionic acid (naproxen). J Pharmacol Exp Ther 1971; 179: 114-23.
10. Scott JA, Clearkin LG. Surgically induced diffuse scleritis following cataract surgery. Eye 1994; 8: 292-7.
11. Fleisher LN, Ferrell JB, Smith MG, et al. Lipid mediators of tumor necrosis factor-alpha-induced uveitis. Invest Ophthalmol Vis Sci 1991; 32: 2393-9.
12. Gupta SK, Joshi S. Role of naproxen as anti-oxidant in selenite cataract. Ophthalmic Res 1994; 26: 226-31.
13. Parys-Van Ginderdeuren R, Malcolm D, et al. Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal anti-inflammatory drugs. Invest Ophthalmol Vis Sci 1992; 33: 3378-84.
14. Podos SM, Becker B. Comparison of ocular prostaglandin synthesis inhibitors. Invest Ophthalmol 1976; 15: 841-4.
15. Nielsen CB. The effect of the prostaglandin-inhibitor naproxen on the endothelial cell-loss after cataract extraction. Acta Ophthalmol (Copenh) 1983; 61: 102-7.
16. Nielsen CB. Prostaglandin inhibition and central corneal thickness after cataract extraction. Acta Ophthalmol (Copenh) 1982; 60: 252-8.
17. Bucolo C, Spadaro A. Effect of sodium naproxen on inflammatory response induced by anterior chamber paracentesis in the rabbit. J Pharm Pharmacol 1995; 47: 708-12.
18. Spampinato S, Marino A, Bucolo C, et al. Effects of sodium naproxen eye drops on rabbit ocular inflammation induced by sodium arachidonate. J Ocul Pharmacol 1991; 7: 125-33.
19. Papa V, Milazzo G, Santocono M, et al. Naproxen ophthalmic solution to manage inflammation after phacoemulsification. J Cataract Refract Surg 2002; 28: 321-7.
20. Papa V, Russo S, Russo P, et al. Topical naproxen sodium for inhibition of miosis during cataract surgery. Prospective, randomized clinical trials. Eye 2002; 16: 292-6.
21. Roberts CW, Brennan KM. A comparison of topical diclofenac with prednisolone for postcataract inflammation. Arch Ophthalmol 1995; 113: 725-7.
22. Kraff MC, Martin RG, Neumann AC, et al. Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation. J Cataract Refract Surg 1994; 20: 138-44.
23. Laurell CG, Zetterstrom C. Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. Br J Ophthalmol 2002; 86: 1380-4.
24. Papa V, Aragona P, Scuderi AC, et al. Treatment of acute bacterial conjunctivitis with topical netilmicin. Cornea 2002; 21: 43-7.
25. Demco TA, Sutton H, Demco CJ, et al. Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery. Eur J Ophthalmol 1997; 7: 236-40.
26. Gaynes BI, Fiscella R. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf 2002; 25: 233-50.
27. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 2000; 107: 2034-8.
28. Flach AJ. Discussion Keratolac vs prednisolone vs combination therapy in the treatment of the acute pseudophakic CMD Ophthalmology 2000; 107: 2039.
29. Flach A. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment. Ophthalmology 2000; 107: 1224-6.
30. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc 2001; 99: 205-12.
31. Congdon NG, Schein OD, von Kulajta P, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs. J Cataract Refract Surg 2001; 27: 622-31.
32. Aragona P, Tripodi G, Spinella R, et al. The effects of the topical administration of non-steroidal anti-inflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects. Eye 2000; 14: 206-10.
33. Papa V, Waitzinger J, Pabst G, et al. Safety and tolerability of naproxen ophthalmic solution in comparison to placebo. Int J Clin Pharmacol Ther 1999; 37: 133-40.